Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05349474 · ClinicalTrials.gov registry record · Early Phase 1
Metformin Treatment in Progressive Multiple Sclerosis
A Early Phase 1 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 23
- Enrollment target
NCT05349474 is a Early Phase 1 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 23 participants.
The verdict
NCT05349474, a Early Phase 1 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety of metformin for treatment of progressive multiple sclerosis
Interventions
- DRUG Metformin 500 Mg Oral Tablet, up to 4 tablets a day
- DRUG Placebo oral tablet identical to metformin, up to 4 tablets a day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-04-26 |
| Est. Completion | 2025-05-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05349474
The ClinicalTrials.gov registry entry for NCT05349474 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metformin 500 Mg Oral Tablet, up to 4 tablets a day is the first listed.
NCT05349474 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05349474 about?
NCT05349474 is a clinical study titled "Metformin Treatment in Progressive Multiple Sclerosis". The purpose of this study is to assess the safety of metformin for treatment of progressive multiple sclerosis
What is the current status of trial NCT05349474?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 23 participants. The study started on 2022-04-26. Estimated completion is 2025-05-30.
What interventions are being tested in trial NCT05349474?
The interventions under investigation include: Metformin 500 Mg Oral Tablet, up to 4 tablets a day (DRUG), Placebo oral tablet identical to metformin, up to 4 tablets a day (DRUG).
Who is sponsoring clinical trial NCT05349474?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.